IF WE HAVE A RESEARCH LINK TO A WEBSITE WHERE WE SELL PRODUCTS OR HAVE PRODUCT INFORMATION, THIS DISCLAIMER INDICATES THAT WHEN YOU LEAVE CANNAKI.COM WEBSITE AND VISIT EXTERNAL LINKS, THE LINKS TO ANY INFORMATIONAL OR EDUCATIONAL WEBSITES ARE PROVIDED SOLELY AS A SERVICE TO OUR USERS. EXTERNAL LINKS PROVIDE ADDITIONAL INFORMATION THAT MAY BE USEFUL OR INTERESTING BUT ARE IN NO WAY AFFILIATED TO OR INTENDED FOR THE PROMOTION, SALE AND DISTRIBUTION OF CANNAKI PRODUCTS. THOSE LINKS DO NOT CONSTITUTE AN ENDORSEMENT OF THESE ORGANIZATIONS BY CANNAKI AND NONE SHOULD BE INFERRED.
Everyday new and
exciting information seems to surface as research grows by leaps and
Below is a small sampling:
Science Shows How CBD Benefits Our Health.
To treat schizophrenia, 40-1,280 milligrams of CBD has been taken by mouth daily for up to four weeks. – To treat epilepsy, 200-300 milligrams of CBD has been taken by mouth daily for up to 4.5 months.
The key is a strain of marijuana that is high in the active substance Cannabidiol (CBD) but very low in THC, the chemical that gets you high.
Recent advances in cannabinoid pharmacology alongside the discovery of the endocannabinoid system (ECS) have re-ignited interest in cannabis-based medicines.
Some disorders seem to trigger a ‘protective’ upregulation of certain cannabinoid CB1 or CB2 receptors that, when activated, can slow the progression of these disorders or ameliorate their symptoms.
Cannabidiol (CBD) is a constituent non-psychotomimetic of Cannabis sativa with great psychiatric potential, including uses as an antidepressant-like and anxiolytic-like compound.
Studies using animal models of anxiety and involving healthy volunteers clearly suggest an anxiolytic-like effect of CBD. Moreover, CBD was shown to reduce anxiety in patients with social anxiety disorder.